Is ATIXF or MRK a better dividend investment in 2026?

ATIXF currently yields 14285.71% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: ATIXF offers higher current income.

What is the dividend yield difference between ATIXF and MRK?

ATIXF has a forward dividend yield of 14285.71% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 14282.95 percentage points.

Home › Compare › ATIXF vs MRK

ATIXF vs MRK: Dividend Comparison 2026

ATIXF yields 14285.71% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ATIXF wins by $1868328188208921344.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ATIXF

● Live price

14285.71%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1868328188208921344.00M

Annual income

$1,842,950,648,126,759,800,000,000.00

Full ATIXF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — ATIXF vs MRK

📍 ATIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ATIXF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ATIXF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ATIXF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATIXF

Annual income on $10K today (after 15% tax)

$1,214,285.71/yr

After 10yr DRIP, annual income (after tax)

$1,566,508,050,907,746,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, ATIXF beats the other by $1,566,508,050,907,746,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATIXF + MRK for your $10,000?

ATIXF: 50%MRK: 50%

100% MRK50/50100% ATIXF

Portfolio after 10yr

$934164094104460672.00M

Annual income

$921,475,324,063,379,900,000,000.00/yr

Blended yield

98.64%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ATIXF

No analyst data

Altman Z

-8.2

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATIXF buys

MRK buys

No recent congressional trades found for ATIXF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricATIXFMRK

Forward yield	14285.71% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$1868328188208921344.00M ✓	$56.8K
Annual income after 10y	$1,842,950,648,126,759,800,000,000.00 ✓	$9,798.13
Total dividends collected	$1866648039868218112.00M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ATIXF vs MRK ($10,000, DRIP)

Year	ATIXF Portfolio	ATIXF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$1,439,271	$1,428,571.43	$11,206	$366.19	+$1.43M → ATIXF
2	$193,699,090	$192,159,069.24	$12,650	$502.35	+$193.69M → ATIXF
3	$24,376,441,818	$24,169,183,791.94	$14,407	$694.19	+$24376.43M → ATIXF
4	$2,868,716,750,186	$2,842,633,957,441.24	$16,585	$967.82	+$2868716.73M → ATIXF
5	$315,716,708,842,374	$312,647,181,919,674.60	$19,342	$1,363.89	+$315716708.82M → ATIXF
6	$32,495,195,455,130,188	$32,157,378,576,668,850.00	$22,913	$1,947.19	+$32495195455.11M → ATIXF
7	$3,128,044,259,554,657,300	$3,093,274,400,417,667,600.00	$27,662	$2,823.89	+$3128044259554.63M → ATIXF
8	$281,631,115,249,329,080,000	$278,284,107,891,605,600,000.00	$34,159	$4,173.35	+$281631115249329.06M → ATIXF
9	$23,717,327,179,590,366,000,000	$23,415,981,886,273,583,000,000.00	$43,337	$6,308.80	+$23717327179590368.00M → ATIXF
10	$1,868,328,188,208,921,400,000,000	$1,842,950,648,126,759,800,000,000.00	$56,776	$9,798.13	+$1868328188208921344.00M → ATIXF

ATIXF vs MRK: Complete Analysis 2026

ATIXF — Stock

AnalytixInsight Inc. operates as a data analytics and enterprise software solutions provider to worldwide institutions across various industries. It develops and markets cloud-based platforms, providing financial content, stock trading, and research solutions for banks, brokers, and investors in the financial services industry. The company also holds a 49% interest in Marketwall SRL, a developer of FinTech solutions for financial institutions. In addition, it offers financial research and content for investors, information providers, finance portals, and media through its online portals and Connect platform; and system integration services for the workforce management industry. The company was formerly known as OMT Inc. and changed its name to AnalytixInsight Inc. in July 2013. AnalytixInsight Inc. was incorporated in 1999 and is headquartered in Toronto, Canada.

Full ATIXF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this ATIXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATIXF vs SCHD ATIXF vs JEPI ATIXF vs O ATIXF vs KO ATIXF vs MAIN ATIXF vs JNJ ATIXF vs ABBV ATIXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.